Clinical trial
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
NCT06409390
Study timeline
Study start (actual)2024-08-14Date precision: day
Registry last updated2025-12-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Interventions
TaxotereDRUG
CytoxanDRUG
Trastuzumab deruxtecanDRUG · verified · RxNorm: trastuzumab deruxtecan
Sacituzumab govitecanDRUG · verified · RxNorm: sacituzumab govitecan
XelodaDRUG · verified · RxNorm: Xeloda
FulvestrantDRUG · verified · RxNorm: fulvestrant
RibociclibDRUG · verified · RxNorm: ribociclib
AbemaciclibDRUG · verified · RxNorm: abemaciclib
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06409390 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.